Nasdaq Offices | Stockholm | Sweden August 28-29, 2019 #LSXNORDIC
Showcasing Companies Already Confirmed!
Presenter Jamal Al Mosleh, CEO
Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company in the Annexin A5 field, for treatment of various cardiovascular diseases, which are currently the most common cause of death.
LSX is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.